Search
for
Sort by
Research 181–210 of 1000+
- Clinical aspects of the metabolic syndrome
- Mucocutaneous Manifestations of Endocrine Disorders
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Comparative evaluation of sonographic ovarian morphology of Indian women with polycystic ovary syndrome versus those of normal women
- Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Inositol versus Metformin administration in polycystic ovary syndrome patients
- Definition criteria and diagnostic assessments
- Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
- Potential role and therapeutic interests of myo-inositol in metabolic diseases
- Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
- Alopecia and its association with coronary heart disease and cardiovascular risk factors: A meta-analysis
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Prevalence of Hyperandrogenic States in Late Adolescent and Young Women: Epidemiological Survey on Italian High-School Students
- Efectos de la disminución de los depósitos tisulares de hierro sobre los factores de riesgo cardiovascular en pacientes con hiperandrogenismo ovárico funcional
- Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- Adult polycystic ovary syndrome begins in childhood
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- PCOS in Adolescence and Type 2 Diabetes
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment